시장보고서

상품코드

1485770

플라스미드 DNA 수탁제조 시장 : 플라스미드 크기 및 복잡도별, 서비스 유형별, 치료 분야별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Plasmid DNA Contract Manufacturing Market, By Plasmid Size and Complexity, By Service Type, By Therapeutic Area, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

플라스미드 DNA 수탁제조 시장 규모는 2023년 3억 8,154만 달러로 2024-2032년 연평균 19.43% 성장할 것으로 예상됩니다.

플라스미드 DNA 수탁제조 시장 - 시장 역학

플라스미드(pDNA) DNA에 대한 수요 증가와 시장 주요 기업들의 R&D 활동 활성화

플라즈미드 DNA에 대한 수요는 저명한 시장 진입 기업들의 활발한 연구개발 활동으로 인해 눈에 띄게 증가하고 있습니다. 이러한 추세는 유전자 치료, 백신 개발, 유전공학 등 다양한 생명공학 분야에서 플라스미드 DNA의 중요성이 커지고 있음을 보여줍니다. 또한, 위탁 생산 기관도 플라스미드 DNA 시장 확대에 기여하고 있습니다. 이러한 노력은 미충족 의료 수요를 충족시키고 생명공학 분야의 기술 혁신을 촉진하기 위한 것입니다.

플라스미드 DNA 수탁제조 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 19.43%의 CAGR로 성장할 것으로 예상됩니다.

플라즈미드의 크기 및 복잡도 세분화 측면에서 대형 플라스미드는 2023년 가장 큰 시장 점유율을 보였습니다.

서비스 유형별로는 플라스미드 DNA 제조가 2023년 주요 유형으로 나타났습니다.

치료 영역별로는 종양학이 2023년 주요 치료 분야로 부상했습니다.

지역별로는 북미가 2023년 매출 1위

플라스미드 DNA 수탁제조 시장 - 세분화 분석:

세계 플라스미드 DNA 수탁제조 시장은 플라스미드 크기 및 복잡성, 서비스 유형, 치료 분야, 응용 분야, 지역에 따라 세분화됩니다.

시장은 플라스미드 크기와 복잡성에 따라 세 가지 범주로 나뉩니다: 플라스미드는 다양한 크기와 복잡성을 가지고 있으며, 다양한 유전공학 수요를 충족시킵니다. 소형 플라스미드는 기본적인 유전공학 작업에 이상적인 소형 DNA 분자이며, 대형 플라스미드는 더 큰 유전자 전달 능력을 제공하여 첨단 생명공학 응용에 적합합니다.

시장은 서비스 유형에 따라 네 가지 범주로 나뉩니다: 플라스미드 DNA 수탁제조은 생산, 최적화, 시험, 제형화 등 다양한 서비스를 포함합니다. 플라스미드 DNA 위탁 생산은 생산, 최적화, 시험, 제형화 등 다양한 서비스를 포함합니다. 분석 테스트는 제품의 품질을 보장하고, 제형화 및 충전 마무리 서비스는 제품 유통을 준비합니다.

플라스미드 DNA 수탁제조 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 나뉩니다. 이 지역들은 사업 진출 국가에 따라 더 세분화되어 있습니다.

북미는 생명공학 및 제약 기업의 존재감이 높고 규제 프레임워크가 잘 갖추어져 있어 시장 점유율에서 선두를 달리고 있습니다. 유럽은 연구개발에 대한 활발한 투자와 잘 구축된 바이오 제조 인프라로 인해 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양은 생명공학 및 위탁생산 서비스에 대한 투자 증가로 인해 큰 성장 잠재력을 보여주고 있습니다.

플라스미드 DNA 수탁제조 시장 - 경쟁 상황:

주요 진입 기업으로는 Aldevron, Catalent, Thermo Fisher Scientific과 같은 기존 바이오의약품 위탁생산(CMO) 업체들이 있습니다. 이들 기업은 플라스미드 DNA 생산부터 정제, 분석 테스트에 이르기까지 종합적인 서비스를 제공하고 있습니다. 또한, 신생 CMO와 바이오테크 스타트업은 전문 지식과 틈새 서비스를 제공함으로써 시장의 다양성에 기여하고 있습니다. 위탁생산업체와 생명공학 기업 간의 경쟁은 각 기업이 혁신적인 솔루션을 제공하고 세계 입지를 넓히기 위해 노력하면서 더욱 치열해지고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 플라스미드 DNA 수탁제조 업계

경쟁 대시보드
기업 개요
- Aldevron, LLC
- Catalent, Inc.
- Cell and Gene Therapy Catapult(CGT Catapult)
- Cobra Biologics(Cognate BioServices의 자회사)
- Codex DNA, Inc.
- Eurofins Scientific
- Fujifilm Diosynth Biotechnologies
- Kaneka Corporation
- Lonza Group Ltd.
- MilliporeSigma(Merck KGaA 사업)
- PlasmidFactory GmbH &Co. KG
- Sirion Biotech GmbH
- Thermo Fisher Scientific Inc.
- VGXI, Inc.(GeneOne Life Science Inc.의 자회사)
- Wuxi Biologics
- 기타

제13장 애널리스트의 전방위 전망

ksm 24.06.05

REPORT HIGHLIGHT

Plasmid DNA Contract Manufacturing Market size was valued at USD 381.54 Million in 2023, expanding at a CAGR of 19.43% from 2024 to 2032.

The Plasmid DNA Contract Manufacturing Market involves the outsourcing of production processes related to plasmid DNA, which is widely used in biotechnology and pharmaceutical research. The rising demand for gene therapy and vaccine development boosted the growth of contract manufacturing services for plasmid DNA. However, restraints such as regulatory challenges and the complexity of manufacturing processes pose hurdles to market expansion. Opportunities lie in the rising investments in biotechnology and the development of novel therapies, which create a conducive environment for contract manufacturers to capitalize on the growing demand for plasmid DNA.

Plasmid DNA Contract Manufacturing Market- Market Dynamics

The increasing demand for plasmid (pDNA) DNA and increasing research and development activities by key players in the market

The demand for plasmid DNA is witnessing a notable upsurge, driven by increasing research and development activities undertaken by prominent market players. This trend is indicative of the growing importance of plasmid DNA in various biotechnological applications, including gene therapy, vaccine development, and genetic engineering. Furthermore, contract manufacturing organizations are contributing to the expansion of the plasmid DNA market. These efforts are aimed at addressing unmet medical needs and driving innovation in the biotechnology sector.

Plasmid DNA Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.43% over the forecast period (2024-2032)

Based on Plasmid Size and Complexity segmentation, Large Plasmids were predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Plasmid DNA Manufacturing was the leading type in 2023

Based on Therapeutic Area segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Plasmid DNA Contract Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Contract Manufacturing Market is segmented on the basis of Plasmid Size and Complexity, Service Type, Therapeutic Area, Application, and Region.

The market is divided into three categories based on Plasmid Size and Complexity: Plasmids come in different sizes and complexities, catering to various genetic engineering needs. Small plasmids are compact DNA molecules ideal for basic genetic engineering tasks, while large plasmids offer greater gene-carrying capacity, suiting advanced biotechnology applications.

The market is divided into four categories based on Service Type: Plasmid DNA contract manufacturing offers diverse services, including production, optimization, testing, and formulation. Analytical testing ensures product quality, while formulation and fill-finish services prepare products for distribution.

Plasmid DNA Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America leads in market share due to a strong presence of biotechnology and pharmaceutical companies, coupled with favorable regulatory frameworks. Europe follows closely, with robust investments in research and development and a well-established biomanufacturing infrastructure. The Asia-Pacific region shows significant growth potential, driven by increasing investments in biotechnology and contract manufacturing services.

Plasmid DNA Contract Manufacturing Market- Competitive Landscape:

Several key players include established biopharmaceutical contract manufacturing organizations (CMOs) such as Aldevron, Catalent, and Thermo Fisher Scientific. These companies offer comprehensive services ranging from plasmid DNA production to purification and analytical testing. Additionally, emerging CMOs and biotechnology startups contribute to market diversity, offering specialized expertise and niche services. Collaboration between contract manufacturers and biotechnology firms further intensifies competition, as companies strive to offer innovative solutions and expand their global footprint.

Recent Developments:

In March 2024, Novel Bio entered into a product development and scale-up agreement with Culture Biosciences to produce plasmid DNA. According to the agreement, Novel Bio will assist Culture Biosciences in expediting the development of scalable fermentation processes for their proprietary NBx Platform(TM), aimed at enhancing plasmid DNA production.

In June 2023, INADcure Foundation unveiled a manufacturing partnership with Charles River Laboratories. In this collaboration, Charles River Laboratories will oversee the production of high-quality plasmid DNA (pDNA) for phase I/II clinical trials focused on a gene therapy targeting Infantile Neuroaxonal Dystrophy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aldevron, LLC

Catalent, Inc.

Cell and Gene Therapy Catapult (CGT Catapult)

Cobra Biologics (a subsidiary of Cognate BioServices)

Codex DNA, Inc.

Eurofins Scientific

Fujifilm Diosynth Biotechnologies

Kaneka Corporation

Lonza Group Ltd.

MilliporeSigma (a business of Merck KGaA)

PlasmidFactory GmbH & Co. KG

Sirion Biotech GmbH

Thermo Fisher Scientific Inc.

VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)

Wuxi Biologics

Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY PLASMID SIZE AND COMPLEXITY- MARKET ANALYSIS, 2019 - 2032

Small Plasmids
Large Plasmids
Complex Plasmids (e.g., viral vectors)

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Plasmid DNA Manufacturing
Process Development and Optimization
Analytical Testing and Quality Control
Formulation and Fill-Finish Services
Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Oncology
Genetic Disorders
Infectious Diseases
Rare Diseases
Autoimmune Disorders
Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Gene Therapy
Vaccines
Cell Therapy
Protein Production
Research and Development
Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Plasmid DNA Contract Manufacturing Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Plasmid DNA Contract Manufacturing Market Snippet by Plasmid Size and Complexity
- 2.1.2.Plasmid DNA Contract Manufacturing Market Snippet by Service Type
- 2.1.3.Plasmid DNA Contract Manufacturing Market Snippet by Therapeutic Area
- 2.1.4.Plasmid DNA Contract Manufacturing Market Snippet by Application
- 2.1.5.Plasmid DNA Contract Manufacturing Market Snippet by Country
- 2.1.6.Plasmid DNA Contract Manufacturing Market Snippet by Region
2.2.Competitive Insights

3.Plasmid DNA Contract Manufacturing Key Market Trends

3.1.Plasmid DNA Contract Manufacturing Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Plasmid DNA Contract Manufacturing Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Plasmid DNA Contract Manufacturing Market Opportunities
3.4.Plasmid DNA Contract Manufacturing Market Future Trends

4.Plasmid DNA Contract Manufacturing Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Plasmid DNA Contract Manufacturing Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Plasmid DNA Contract Manufacturing Market Landscape

6.1.Plasmid DNA Contract Manufacturing Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Contract Manufacturing Market - By Plasmid Size and Complexity

7.1.Overview
- 7.1.1.Segment Share Analysis, By Plasmid Size and Complexity, 2023 & 2032 (%)
- 7.1.2.Small Plasmids
- 7.1.3.Large Plasmids
- 7.1.4.Complex Plasmids (e.g., viral vectors)

8.Plasmid DNA Contract Manufacturing Market - By Service Type

8.1.Overview
- 8.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 8.1.2.Plasmid DNA Manufacturing
- 8.1.3.Process Development and Optimization
- 8.1.4.Analytical Testing and Quality Control
- 8.1.5.Formulation and Fill-Finish Services
- 8.1.6.Others

9.Plasmid DNA Contract Manufacturing Market - By Therapeutic Area

9.1.Overview
- 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
- 9.1.2.Oncology
- 9.1.3.Genetic Disorders
- 9.1.4.Infectious Diseases
- 9.1.5.Rare Diseases
- 9.1.6.Autoimmune Disorders
- 9.1.7.Others

10.Plasmid DNA Contract Manufacturing Market - By Application

10.1.Overview
- 10.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 10.1.2.Gene Therapy
- 10.1.3.Vaccines
- 10.1.4.Cell Therapy
- 10.1.5.Protein Production
- 10.1.6.Research and Development
- 10.1.7.Others

11.Plasmid DNA Contract Manufacturing Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Plasmid DNA Contract Manufacturing Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Contract Manufacturing Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Aldevron, LLC
- 12.2.2.Catalent, Inc.
- 12.2.3.Cell and Gene Therapy Catapult (CGT Catapult)
- 12.2.4.Cobra Biologics (a subsidiary of Cognate BioServices)
- 12.2.5.Codex DNA, Inc.
- 12.2.6.Eurofins Scientific
- 12.2.7.Fujifilm Diosynth Biotechnologies
- 12.2.8.Kaneka Corporation
- 12.2.9.Lonza Group Ltd.
- 12.2.10.MilliporeSigma (a business of Merck KGaA)
- 12.2.11.PlasmidFactory GmbH & Co. KG
- 12.2.12.Sirion Biotech GmbH
- 12.2.13.Thermo Fisher Scientific Inc.
- 12.2.14.VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)
- 12.2.15.Wuxi Biologics
- 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us